NON-SQUAMOUS NSCLC

Clinical trials for NON-SQUAMOUS NSCLC explained in plain language.

Never miss a new study

Get alerted when new NON-SQUAMOUS NSCLC trials appear

Sign up with your email to follow new studies for NON-SQUAMOUS NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New pill shows promise against hard-to-treat lung cancer in late-stage trial

Disease control Completed

This study tested a new targeted therapy pill, pyrotinib, against standard chemotherapy (docetaxel) in 151 people with advanced non-squamous lung cancer that has a specific HER2 gene mutation. All participants had already tried platinum-based chemo. The main goal was to see if py…

Matched conditions: NON-SQUAMOUS NSCLC

Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

NON-SQUAMOUS NSCLC

Get alerted when new NON-SQUAMOUS NSCLC trials appear

New pill shows promise against hard-to-treat lung cancer in late-stage trial